January 9,
2023 1032 1032
The State Medical Board of Ohio has public meetings scheduled this week.
Monday, January 9, 2023
The Dietetics Advisory Council is meeting in-person at 2 p.m. Click here to view the agenda.
Wednesday, Jan. 11, 2023
The following meetings will be shared on the board's YouTube channel, as technology permits. Click here to view the agenda and livestream link.
8 a.m. Quality Assurance Committee
8:30 a.m. Compliance Committee
9 a.m. Finance Committee
10 a.m. Board Meeting
December 30,
2022 892 892
The State Medical Board office will be closed on Monday, January 2 in observance of the New Year holiday. We will reopen on Tuesday at 8 a.m.
December 23,
2022 829 829
The State Medical Board office will be closed on Monday, December 26 in observance of Christmas. We will reopen on Tuesday at 8 a.m.
December 23,
2022 2966 2966
On December 22, Governor DeWine signed Executive Order 2022-17-D to suspend the normal rulemaking process to allow the State of Ohio Board of Pharmacy to classify all products containing an unregulated drug that produces opioid-like effects, tianeptine, as a Schedule I controlled substance pursuant to OAC 4729:9-1-01.03.
Tianeptine is an atypical tricyclic antidepressant that is not approved by the U.S. Food and Drug Administration (FDA). The drug (marketed as Coaxil or Stablon) is approved for use in in Europe, Asia, and Latin America. In the U.S., tianeptine is known as ZaZa and Tianna Red by users, who can find it readily available in gas stations, convenience stores, and online.
Click here to read the full news release and retailer notice.
December 12,
2022 1013 1013
The State Medical Board of Ohio has public meetings scheduled this week.
Tuesday, December 13
The Respiratory Care Advisory Council is meeting in person at 2 p.m. Click here to view the agenda.
Wednesday, December 14
The following meetings will be shared on the board's YouTube channel, as technology permits. Click here to view the agenda and livestream link.
9 a.m. Compliance Committee
10:00 a.m. Board Meeting
December 5,
2022 1743 1743
Licensees should be aware that a scam is spoofing State Medical Board of Ohio (SMBO) emails. In the above image, scammers sent an email to a licensee under the pretense that they are a legitimate SMBO employee; however, the email address in the body of the email and the email address in the sender portion do not match. All emails from an SMBO sender should end in @med.ohio.gov.
If you are contacted by a scammer, please report the incident to your local law enforcement and Ohio's Attorney General by filing a complaint online at ohioprotects.org or by calling 800-282-0515.
November 21,
2022 2214 2214
The State Medical Board of Ohio (SMBO) was notified of an email (see picture) from a third party vendor that advertises a bundle of mandatory topics for continuing medical education (CME). The email did not originate from SMBO, and the third party vendor is not connected to the board.
Although physicians are required to complete 50 hours of CME each renewal period, the only mandatory CME is one hour on the topic of a licensee’s duty to report for which the board has created a course for licensees to complete. The remaining hours may be earned by completing educational activities that have been awarded Category 1 credit by accredited CME providers such as the Ohio State Medical Association.
Additional information on the duty to report can be found at med.ohio.gov/Duty-to-Report. For more information on CME requirements, licensees may visit the board’s website at https://med.ohio.gov/Renew/Physician/Physician-MD-DO-DPM or contact our Licensure team via license@med.ohio.gov.
November 17,
2022 1692 1692
The State Medical Board of Ohio has released a new Transparency page with clear metrics on the output of its complaint and enforcement processes. This reported data is a continuation of the board’s efforts to provide transparency and appropriate disclosure of case information to the public. Among the changes, the board created a new dashboard that reports submitted and closed complaints, citations and settlement agreements, and allegations of licensee misconduct by calendar year. Click here to view the new Transparency page.